COLD AND SINUS PLUS TABLET
国家: 加拿大
语言: 英文
来源: Health Canada
产品特点
(SPC)
06-10-2016
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
可用日期:
MARCAN PHARMACEUTICALS INC
ATC代码:
M01AE51
INN（国际名称）:
IBUPROFEN, COMBINATIONS
剂量:
2MG; 200MG; 30MG
药物剂型:
TABLET
组成:
CHLORPHENIRAMINE MALEATE 2MG; IBUPROFEN 200MG; PSEUDOEPHEDRINE HYDROCHLORIDE 30MG
给药途径:
ORAL
每包单位数:
10/20/24/40/72/100
处方类型:
OTC
治疗领域:
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
產品總結:
Active ingredient group (AIG) number: 0349765001; AHFS:
授权状态:
APPROVED
授权日期:
2016-09-27
产品特点
1 | P a g e
PRODUCT MONOGRAPH
COLD AND SINUS PLUS
Ibuprofen 200 mg, Pseudoephedrine Hydrochloride 30 mg and
Chlorpheniramine
Maleate 2 mg
Tablets
Analgesic/Antipyretic/Nasal Decongestant/Antihistamine
Date of Preparation:
September 27, 2016
Marcan Pharmaceuticals Inc.
77 Auriga Drive, Unit # 4
Ottawa, Ontario
K2E 7Z7
Submission Control No.: 197591
2 | P a g e
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................................................................
3
SUMMARY PRODUCT INFORMATION
..................................................................................................
3
INDICATIONS AND CLINICAL USE
........................................................................................................
3
CONTRAINDICATIONS
.............................................................................................................................
3
WARNINGS AND PRECAUTIONS
...........................................................................................................
5
ADVERSE REACTIONS
...........................................................................................................................
11
DRUG INTERACTIONS
............................................................................................................................
20
DOSAGE AND ADMINISTRATION
........................................................................................................
24
OVERDOSAGE
..........................................................................................................................................
24
ACTION AND CLINICAL PHARMACOLOGY
......................................................................................
27
STORAGE AND STABILITY
....................................................................................................................
33
SPECIAL HANDLING INSTRUCTIONS
.................................................................................................
33
DOSAGE FORMS, COMPOSITIO
阅读完整的文件
